合成转录因子工程用于细胞和基因治疗
Bhoomi Bhatt1, Pablo García-Díaz1, Glenna Wink Foight2
1Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, TX, USA.
Trends in biotechnology
|October 21, 2023
概括
合成转录因子 (synTFs) 通过使用人类衍生成分提供更安全的细胞和基因疗法. 这些进展克服了免疫性问题,为临床应用铺平了道路.
科学领域:
- 合成生物学 合成生物学
- 基因治疗是一种基因疗法.
- 分子工程是分子工程.
背景情况:
- 合成转录因子 (synTFs) 对于控制细胞和基因治疗中的转基因表达至关重要.
- 目前对非人类synTF成分的依赖引起了人们对免疫性和药物特性的担忧.
- 这些安全性和有效性挑战阻碍了synTF开发的进展.
研究的目的:
- 为了解决非人类synTF组件的局限性.
- 突出最近在开发人类衍生的synTFs方面取得的进展.
- 讨论用于临床转换的新型控制模块和电路设计的潜力.
主要方法:
- 工程人类衍生的DNA结合域 (DBDs) 和转录激活域 (TADs).
- 开发针对临床批准的小分子反应的新型控制模块.
- 设计复杂的,多输入的synTF电路和可通过自主信号输入诱导的控制器.
主要成果:
- 人类衍生DBDs和TADs与新控制模块的成功配对.
- 开发先进的synTF架构,包括自主和多输入系统.
- 在临床相关的载体和体内模型中展示先进的控制策略.
结论:
- 人类衍生的synTFs可以克服免疫性和药物特性方面的担忧.
- 新的控制模块和复杂的电路提高了synTF技术的安全性和有效性.
- 在临床环境中进一步验证对于推进基于synTF的疗法至关重要.
更多相关视频
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
General Transcription Factors
5.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K
Combinatorial Gene Control
8.4K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.4K
Transcription Factors
76.0K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
76.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


